About Us

Slowave is a digital neuro-healthcare company supporting clinical decision-making through wearable EEG sensors and advanced signal analysis technology. We are establishing a data-driven medical environment where neuropsychiatric disorders can be objectively understood and managed through brain signal data.

What We Do

We develop proprietary lightweight, wireless patch-type EEG devices and precision brain signal analysis algorithms. Our mission is to create technologies that can be practically applied in clinical settings, researching EEG-based diagnostic support solutions for various neuropsychiatric conditions, including sleep disorders, delirium, and ADHD.

Vision

Bringing EEG into Daily Life

Slowave aims to expand into a precision neuromedicine system that bridges brain signal analysis and treatment, growing into a global neuro-tech leader that pioneers data-driven neurological disease management.

History

Company history

2022. 11

Established Slowave Inc.

2023. 05

Selected for the Early-stage Startup Package (Ministry of SMEs and Startups)

2023. 06

Designated as an Outstanding (Star) Venture by KIBO Camp

2023. 07

Secured Seed Investment from SparkLabs and three other VCs

2023. 11

Selected for Deep-tech TIPS (Fast-track); Registered as a Certified Venture Business

2024. 01

Opened R&D Center (Anyang-si, Korea)

2024. 02

Commenced Data Analysis Collaboration with the Delirium Data Center (MIT-Michigan)

2024. 03

Awarded 'Excellent' in the Final Performance Evaluation of the Early-stage Startup Package

2024. 04

Selected for the Startup Leap Package

2025. 01

Selected for the Bio-Core Facility Project

2025. 03

Obtained GMP and CB Certifications

2025. 09

Obtained MFDS (KFDA) Class II Medical Device Certification

2025. 11

Secured Pre-A Investment from Korea Technology Finance Corporation (KIBO)